Your browser doesn't support javascript.
loading
Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.
Doan, Tan N; Kirkpatrick, Carl M J; Walker, Patricia; Slavin, Monica A; Ananda-Rajah, Michelle R; Morrissey, C Orla; Urbancic, Karen F; Grigg, Andrew; Spencer, Andrew; Szer, Jeffrey; Seymour, John F; Kong, David C M.
Afiliação
  • Doan TN; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
  • Kirkpatrick CM; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.
  • Walker P; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health, Melbourne, Victoria, Australia.
  • Slavin MA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia University of Melbou
  • Ananda-Rajah MR; General Medicine Unit, Alfred Health, Melbourne, Victoria, Australia Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia.
  • Morrissey CO; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health, Melbourne, Victoria, Australia Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, Australia Department of Infectious Diseases, Monash University, Melbourne, Victoria, Australia Department of Haematology,
  • Urbancic KF; Pharmacy Department, Austin Health, Melbourne, Victoria, Australia Infectious Diseases Department, Austin Health, Melbourne, Victoria, Australia.
  • Grigg A; University of Melbourne, Melbourne, Victoria, Australia Department of Clinical Haematology, Austin Health, Melbourne, Victoria, Australia.
  • Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health, Melbourne, Victoria, Australia Department of Haematology, Monash University, Melbourne, Victoria, Australia.
  • Szer J; University of Melbourne, Melbourne, Victoria, Australia Department of Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Seymour JF; University of Melbourne, Melbourne, Victoria, Australia Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Kong DC; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia david.kong@monash.edu.
J Antimicrob Chemother ; 71(2): 497-505, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26518050
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioprevenção / Leucemia-Linfoma Linfoblástico de Células Precursoras / Micoses / Antifúngicos Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Oceania Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quimioprevenção / Leucemia-Linfoma Linfoblástico de Células Precursoras / Micoses / Antifúngicos Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Oceania Idioma: En Ano de publicação: 2016 Tipo de documento: Article